Position in INCY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$460,468
+$95,753 QoQ
Shares Held
4,062
+4.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#535
of 854 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Perigon Wealth Management, LLC holds $16,607,198 across 16 Biotechnology names. INCY ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,164 | $4,467,040 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,834 | $4,388,112 | |
| 3 | FDMT |
4D Molecular Therapeutics, Inc.
|
146,185 | $1,944,260 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
22,976 | $1,253,111 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
2,551 | $726,958 | |
| 6 | VERA |
Vera Therapeutics, Inc.
|
15,850 | $680,123 | |
| 7 | BNTX |
BioNTech SE
|
5,837 | $543,132 | |
| 8 | INCY |
Incyte Corp
This page
|
4,062 | $460,468 |
All Filings in INCY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $460,468 | 4,062 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $364,715 | 3,875 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $537,605 | 5,443 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $455,005 | 5,365 | Shares | Sole | 2025-10-17 | |
| No filing history on record for this holder in this stock. | ||||||